Evidence digest
Surgical Retina & Vitreous: the evidence, summarized every weekday
Peer-reviewed papers in surgical retina & vitreous, summarized and ranked by evidence level. Top studies from PubMed and ClinicalTrials.gov. Updated every weekday at 06:00 CET. Built by physicians, for physicians.
What rounds. covers in surgical retina & vitreous
- Rhegmatogenous RD
- Macular hole & ERM
- PVR
- Endophthalmitis
- Submacular hemorrhage
- Pediatric vitreoretinal (ROP)
Landmark papers · surgical retina & vitreous
Hand-picked by the editorial team. These are the studies that shaped current practice in surgical retina & vitreous.
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
The New England journal of medicine · Mintz‐Hittner H. et al. · Saturday, January 1, 2011
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.
The New England journal of medicine · Stalmans P. et al. · Sunday, January 1, 2012
How papers reach the surgical retina & vitreous brief
- Source. Every paper is fetched directly from PubMed and ClinicalTrials.gov. No paywalled aggregators. No editorial press releases.
- Grading. Each paper is assigned an evidence level from L1 (RCT or meta-analysis) to L5 (editorial). Bias risk is flagged separately. Both labels are visible on every card.
- Summarization. A 5-gate validator stack checks every summary for source faithfulness, numeric accuracy, drug-safety language, unsupported claims, and clinical-decision overreach. Anything that fails a gate is blocked, not silently weakened.
- Delivery. Ten papers. Twelve minutes. Every weekday at 06:00 CET. Subscribers can rate any paper as off-topic and it drops out of their feed.
The full pipeline, validators, and the founder's editorial overrides are documented on the methodology page.
Frequently asked
- How do I keep up with new surgical retina & vitreous research?
- rounds. reads the new surgical retina & vitreous literature from PubMed and ClinicalTrials.gov every weekday, grades each paper on the CEBM evidence hierarchy, and delivers the few that change practice as a twelve-minute morning brief. Every summary is checked claim by claim against the source paper.
- What are the landmark surgical retina & vitreous trials?
- The studies that shaped current surgical retina & vitreous practice are listed above under “Landmark papers”, each linked to a structured summary with its evidence level, effect size, and bias signals.
- Is rounds. free?
- The morning scan is free. Pro (€49 / year) unlocks the full ten-paper daily brief, the full read on every paper, and the 06:00 CET email, Monday to Friday.